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The presence of melanocytes in the oral epithelium is a well-established fact, but their physiological functions are
not well defined. Melanin provides protection from environmental stressors such as ultraviolet radiation and
reactive oxygen species; and melanocytes function as stress-sensors having the capacity both to react to and to
produce a variety of microenvironmental cytokines and growth factors, modulating immune, inflammatory and
antibacterial responses. Melanocytes also act as neuroendocrine cells producing local neurotransmitters including
acetylcholine, catecholamines and opioids, and hormones of the melanocortin system such as proopiomelanocortin,
adrenocorticotropic hormone and α-melanocyte stimulating hormone, that participate in intracellular and in
intercellular signalling pathways, thus contributing to tissue homeostasis.
There is a wide range of normal variation in melanin pigmentation of the oral mucosa. In general, darker skinned
persons more frequently have oral melanin pigmentation than light-skinned persons. Variations in oral physiological
pigmentation are genetically determined unless associated with some underlying disease.
In this article, we discuss some aspects of the biophysiology of oral melanocytes, of the functions of melanin, and of
physiological oral pigmentation.
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transferIntroduction
While under physiological conditions the number of mela-
nocytes in the oral epithelium is the same regardless of
racial/ethnic origin [1], the colour of oral mucosa varies
between persons and is determined by several factors
including the number and melanogenic activity of the me-
lanocytes in the basal cell layer of the epithelium, differ-
ences in number, size, and distribution of melanosomes,
differences in the type of melanins, and the masking effect
of heavily keratinized epithelium [2-4]. The variations in
melanin colourisation of the oral mucosa will be deter-
mined against a background of the degree of vascula-
rization of the tissues and by the level of haemoglobin in
the blood [2].
Melanocytes containing melanin are present in the
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unless otherwise stated.mucosal sites that show no visible signs of melanin pig-
mentation [5-7]. Oral melanocytes may or may not pro-
duce melanin, but as in the case of the skin, the amount
of melanin they produce is genetically determined [2,6].
There are substantial variations in the degree of melanin
pigmentation between persons of different racial/ethnic
groups and between persons of the same racial/ethnic
group, and these variations are normal [2,8,9]. Phy-
siological/racial melanin pigmentation of the oral mu-
cosa is common in black persons [7], and is more
frequent in darker skinned whites (Caucasians) than in
lighter skinned whites [10]. The oral mucosal melanin
pigmentation may be patchy or uniform and most com-
monly affects the gingiva [9].
Melanocytes produce melanin in membrane-bound or-
ganelles termed melanosomes. Melanosomes have all the
proteins and enzymes necessary for melanin biosynthesis,
for maintaining the structure of the melanosome, and for
the maturation of the immature pre-melanosome into a
mature melanosome producing melanin [11,12]. As the
melanosomes mature intracellularly, they are transportedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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of the melanocytes whence they are ultimately transferred
to the keratinocytes in the ‘keratinocyte melanin unit’
[11,12]. Within the keratinocytes, the melanin is preferen-
tially localised within the nuclei forming protective bar-
riers known as supranuclear ‘caps’ oriented in such a way
that they shield the nuclear DNA from ultraviolet (UV)
radiation [13].
Non-physiological alterations in melanin pigmentation
of the oral mucosa are related to genetic, metabolic, endo-
crine, chemical or physical factors, to infective agents and
to inflammatory or neoplastic processes [6,9]. It has been
reported that in about 30% of cases, oral mucosal mela-
noma develops at sites of hyperpigmentation [2,14]. How-
ever, the nature of the hyperpigmented pre-melanoma is
obscure.
Most of our knowledge about the regulation and biology
of oral melanocytes is derived from data obtained from
research on epidermal melanocytes which are histologi-
cally and ultra-structurally similar [15,16]. However, when
extrapolating data from epidermal melanocytes, one needs
to bear in mind that as a rule, oral mucosal melanocytes
under physiological circumstances are said to be less me-
tabolically active [6]. Nevertheless, in some cases oral
melanocytes may be inherently metabolically active, and
in other cases an increase in metabolic activity may be in
response to environmental triggers such as hormones,
inflammation or injury [6].
The aim of this short review is to discuss some aspects
of the biology and physiology of oral melanocytes, the
function of melanin and critically to evaluate the con-
cept of intraoral physiological pigmentation.
The origin of oral melanocytes
Melanocytes are melanin-producing cells originating from
the neural crest [17]. During development melanocyte
stem cells migrate from the neural crest to the skin and to
mucous membranes. Active melanocytes are present in
the stria vascularis of the cochlea, in the leptomeninges, in
the substantia nigra and locus coerulus of the brain, and
in the heart, where they play a number of as yet ill-defined
roles [13,18].
Melanocyte stem cells have the capacity for self-renewal
and for differentiation and thus can maintain the popula-
tion of mature melanocytes. In the epidermis, the melano-
cyte stem cells reside in the bulge region of hair follicles
[19,20], but the niche in which they reside in the oral mu-
cosa is unknown.
Epidermal melanocyte stem cells give rise to transient-
amplifying melanocyte precursors that settle without the
stem cell niche where they differentiate into mature mela-
nin producing melanocytes [19,21-24]. Stem cell factor
(SCF) and its tyrosine kinase receptor C-kit signalling path-
ways are critical for epidermal melanocyte developmentduring embryogenesis [17,20], notch signalling pathways
are essential in the maintenance of adult melanocyte stem
cells, and thus for melanocyte homeostasis [20], endothelin
1 plays a role in the differentiation of melanocyte pre-
cursors, and micropthalmia-associated transcription factor
(MITF) with its cAMP response element play a critical role
in melanogenesis [25].
In the skin, migration of precursor melanocytes from
the dermis to their final destination in the basal cell layer
of the epithelium is mediated by c-Kit/SCF, endothelin 1
and 3, hepatocyte growth factor (HGF) and basic fibro-
blast growth factor (bFGF). These precursor dermal mela-
nocytes, as they pass through the basement membrane,
express E-cadherin which later facilitates intercellular
communication with neighbouring keratinocytes in the
basal cell layer of the epithelium [1]. Sometimes, mela-
nocyte precursors on their way to the epithelium may be-
come arrested in the lamina propria/dermis, and as they
have the capacity to produce melanin, if they are aggre-
gated they will form nevi [26]. The functional activity of
melanocytes, both those in the basal cell layer of the epi-
thelium and those that may have become arrested in the
lamina propria is influenced by signals from the neigh-
bouring fibroblasts [13,27,28].
The keratinocyte-melanocyte unit
Mature melanocytes are elongated dendritic cells resid-
ing in the basal cell layer of the epithelium. They contain
all the proteins required for melanin biosynthesis and
for the structural maturation of melanosomes [12], in-
cluding tryosinase (TYR), tyrosinase-related proteins-1
(TRP-1) and TRP-2, gp 100, and melanoma antigen re-
cognizable by T lymphocytes (MART-1) [13,29-31].
In the basal cell layer of the epithelium the ratio of
melanocytes to keratinocytes ranges from 1:10 [30] to
1:15 [6]. Melanocytes and keratinocytes form epidermal
melanin units, each unit consists of one melanocyte and
a group of about 36 neighbouring keratinocytes. The
melanosomes produced by melanocytes are disseminated
via a network of melanocytic dendritic processes to the
keratinocytes of the epidermal melanin unit [25,32]. It
appears that keratinocytes have some control over the
process of dendritic melanosome transfer since the capa-
city of keratinocytes to phagocytose the melanosomes is
influenced by the degree of activation of the protease-
activated receptor 2 (PAR-2) on the surface of keratino-
cytes [33].
It has been suggested that through biological mediators
present in the melanosomes transferred to keratinocytes,
melanocytes can influence the functional activities of kerati-
nocytes [13], and keratinocytes via an array of paracrine-
like biological mediators that they secrete, have the capacity
to regulate melanocyte melanogenesis [13,25,34]. These
mediators include α-melanocyte stimulating hormone
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endorphin, bFGF, endothelins, HGF and SCF [35].
However, such a mechanistic description is an over-
simplification as the ratio of keratinocytes to mela-
nocytes is different at different stages of growth and
development, and in adulthood the ratio is variable
being determined by biological mediators secreted in the
local microenvironment [33]. Furthermore, the nume-
rical density of melanocytes in the epithelium varies in
different parts of the skin or oral mucosa, and between
the same skin or mucosa sites in different persons, re-
gardless of their racial/ethnic origin [36]. It appears that
Langerhans cells in the epithelium, and fibroblasts in the
subepithelial connective tissue play an important role
in maintaining the functional activity of the epidermal
melanin unit [30,31,33].
The adherence of melanocytes to keratinocytes is by
means of tight junctions where they co-express E-cadherin
cell adhesion molecules and by gap junctions [33]. E-
cadherin supresses melanocyte proliferation, but a switch
from E-cadherin to N-cadherin owing to metabolically or
traumatically triggered events in the microenvironment
obviates the melanocytes from growth suppression.
Melanocytes expressing N-cadherin can freely proli-
ferate, migrate and self-aggregate in nests, and exhibit
longevity [32].
The function of oral melanocytes
The functions of melanocytes are not fully understood,
but it is clear that the melanin that they produce deter-
mines the colour of skin, hair and eyes [37], and pro-
vides protection from stressors such as UV radiation,
reactive oxygen species (ROS) and free radicals in the
environment. Melanins also have the capacity to seques-
ter metal ions and to bind certain drugs and organic
molecules [32,38].
The colour of skin and probably of any pigmented part
of the oral mucosa is genetically determined by the
number and size of the melanosomes and the type of
melanin (eumelanin, pheomelanin) that they produce.
Environmental factors have only a modifying influence
on skin colour, though on an evolutionary scale this in-
fluence can have a more profound effect. Melanosomes
vary in size and contain both eumelanin and pheomela-
nin. More, larger eumelanin impart a dark colour to the
skin [33]. Small, few pheomelanin-containing melano-
somes are associated with light skin, and the spectrum
of size and number of melanosomes and the balance of
eumelanin to pheomelanin within the melanosomes, will
determine all the other colour variations [32].
As melanin synthesis is an oxygen dependent process,
paradoxically, it also generates ROS that may accumu-
late in the melanocytes and cause DNA damage, and in
fact UV radiation exaggerates the production of ROSduring the biosynthesis of melanin and more particularly
pheomelanin [39]. Thus, melanin possesses both antioxi-
dant and ROS-dependent cytotoxic properties [18].
Quinones and semiquinones which are intermediates
of melanogenesis are toxic or mutagenic with the po-
tential to cause cytogenetic instability [40]; and L-dopa,
another intermediate of melanogenesis, has the capacity
to inhibit the production of proinflammatory cytokines
by T lymphocytes and monocytes, thus downregulating
immune and inflammatory responses [38,40].
Melanins produced by melanocytes residing in the basal
cell layer of the gingival epithelium have the capacity to
neutralize ROS generated by dentogingival plaque-in-
duced inflammation in the periodontal microenvironment
[16]. Interestingly, a recent report shows that markers of
gingival inflammation are reduced in subjects with pig-
mented gingiva compared to subjects with non-pigmented
gingiva, despite comparable dentogingival plaque levels in
both groups of subjects. However, one needs to bear
in mind that the sulcular and junctional epithelium, in
contrast to the keratinized epithelium usually does not
harbour any melanocytes [16].
Melanosomes contain lysosomal enzymes including
α-mannosidase, acid phosphatase, β-N acetylglycosamini-
dase, β-galactosidase, and acid lipase that can degrade bac-
teria [41]. Melanin itself can neutralise bacteria-derived
enzymes and toxins, and since it has strong binding pro-
perties, it can also act as a physical barrier against mi-
croorganisms [41]. Furthermore, melanocytes can act as
antigen presenting cells, can stimulate T-cell proliferation,
and can phagocytose microorganisms [32,41]. Thus, mela-
nocytes and their products have the capacity to inhibit
proliferation of bacterial and fungal microorganisms [41].
As keratinocytes ascend through the cell layers of the
epithelium and are shed, their melanosomal membranes
undergo degradation with release of melanin ‘dust’ which
becomes entangled in the keratin filaments of the des-
quamating surface cells. This melanin dust inactivates
pathogenic chemicals, microbial toxins and other biologic-
ally active molecules [18]. Therefore, melanocytes and
melanins may be viewed as an integral part of the innate
immune system with a role in neutralising the products of
superficial bacterial and fungal infective agents [41].
It is possible that from an evolutionary point of view,
the primary role of melanocytes is not to produce mela-
nin, for melanin does not confer a selective advantage to
the organisms, but that melanin production is only a
secondary specialization so melanocytes must have other
more important functions to perform [13]. Melanocytes
in skin, and perhaps in oral mucosa express genes en-
coding corticotropin releasing factor (CRF), proopiome-
lanocortin (POMC), ACTH, β endorphins, α-MSH and
melanocortin-1 receptor (MC1R). These elements of the
skin melanocortin system have the capacity to neutralize
Figure 1 Multiple, light brown maculae with well-defined borders
on the gingiva.
Figure 2 Physiological oral pigmentation on the gingiva
presenting as bilateral, symmetrical, dark brown discolouration
of the labial gingiva, including the marginal and papillary
gingiva but not transgressing the mucogingival junction.
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and immune responses, and to mediate local nociception
[34,42]. UV radiation induces the generation of CRF,
POMC and α-MSH by cutaneous keratinocytes and mela-
nocytes, bringing about an increase in melanin biosynthesis
[43], imparting protection against solar radiation [13].
Melanocyte-derived α-MSH, ACTH, and other peptides
of POMC, stimulate the MC1R of neighbouring melano-
cytes, activating an intracellular signalling cascade invol-
ving the second messenger cAMP and the MITF [34]. The
α-MSH/MC1R/cAMP/MITF pathway controls the tran-
scription of tyrosine and is therefore essential for melano-
genesis [25], and also determines the type and quantity of
the melanin produced [1,13].
Regulation of melanogenesis
Melanogenesis comprises a process of oxidation of the
amino acid tyrosine and derived aromatic compounds,
forming two main types of polymeric phenolic com-
pounds. Large, irregular granules of eumelanin which
are black-brown in colour and smaller, more regular
granules of pheomelanin which are yellow-red in colour
[41]. Melanocytes are capable of producing both eume-
lanin and pheomelanin, and the proportion of the two
melanins produced by a particular melanocyte is a func-
tion of availability of tyrosine, of reducing agents, and of
the types of pigment enzymes expressed [1].
The melanocortin system through the cAMP/MITF
pathway can stimulate proliferation of undifferentiated
melanocytes, their maturation with fully formed dendritic
processes, and upregulation of melanogenesis, thus in-
creasing the formation of melanin [42,44]. α-MSH has the
capacity to suppress inflammatory responses, because it
can inhibit nuclear factor-κB (NF-κB) that regulates the
expression of genes of proinflammatory cytokines. Thus,
the same biological mediator of the melanocortin system
that stimulates melanogenesis, also downregulates inflam-
matory responses [33].
It appears that the epidermal adrenergic signalling path-
way plays a role in the regulation of skin pigmentation.
Epidermal melanocytes express α1- and β2-adrenoceptors,
the activation of which leads to an increase in melanin
biosynthesis and a concurrent increase in the number
and complexity of melanocytic dendrites. The adrenalin/
β2-adrenoceptor/cAMP/MITF pathway like the α-MSH
/MC1R/cAMP/MITF pathway has therefore the capacity
to mediate melanin production and its dendritic distri-
bution [44].
β-endorphin, an opioid peptide cleaved from POMC is
positively associated with increased skin pigmentation.
The β-endorphin/μ-opioid receptor/PKCβ isoform sig-
nalling pathway is expressed and functionally active, me-
diating differentiation and maturation of melanocytes
with increased melanogenesis and dendricity [36,45]. Tothe best of our knowledge, the role of melanocortin, ad-
renergic and opioid systems in relation to melanogenesis
in the oral epithelium is unknown.
Mediators of inflammation such as histamine and ara-
chidonic acid metabolites trigger melanogenesis [41],
and inflammatory cytokines such as TNF-α and IL-1α
induce the secretion of melanogenic agents (SCF, HGF,
bFGF, endothelins) by keratinocytes. Together these
agents account for the melanin pigmentation sometimes
observed in association with inflammatory conditions of
skin or oral mucosa [41,46], such as oral lichen planus
[6] and healing after periodontal surgery [47].
Figure 5 Physiological oral pigmentation in a black male: a well
demarcated brown band on the attached gingiva, not
transgressing the mucogingival junction and not affecting the
marginal/interdental papillary gingiva. (The foreign body at the
upper left is a post-biopsy suture).
Figure 3 Diffuse, light brown physiological oral pigmentation
on the hard palate.
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Variation in oral physiological melanin pigmentation is
ascribable to variations in the activity of melanocytes in
the basal cell layer of the oral epithelium. Such oral pig-
mentation is more common in darker-skinned persons re-
gardless of their racial/ethnic origin [10,16]. This strongly
suggests that physiological oral pigmentation is deter-
mined by genetic factors associated with melanogenesis
[15]. Microscopical examination of physiologically pig-
mented oral mucosae shows increased melanin in the
basal cell layer and sometimes in the upper portion of the
lamina propria within melanophages, or simply as extra-
cellular melanin particles [15]. These microscopical fea-
tures are very similar to those found in melanotic maculae
and smoker’s melanosis [3].Figure 4 Uniform dark brown-black pigmentation of the lower
lip and labial mucosa.Physiological oral pigmentation and pathological oral
pigmentations that may be similar in appearance should
be differentiated. Diseases that may be confused with
physiological oral pigmentation include Addison’s dis-
ease, neurofibromatosis, oral melanotic maculae, oral
mucosal melanoma, drug-induced oral mucosal pigmen-
tation, and to a much lesser extent Kaposi sarcoma,
vascular malformations and haemangioma of the oral
mucosa [48].
Physiological melanin pigmentation of the oral mucosa
affects males and females equally, as asymptomatic, soli-
tary or multiple brown maculae with well-defined borders
(Figure 1) [49]. It may involve any part of the oral mucosa
(Figures 2, 3, 4), but most frequently the gingiva [3,48,50].
In the gingivae, pigmentation when it occurs, is most
commonly bilaterally symmetrical and does not transgressFigure 6 Light brown pigmentation of the alveolar mucosa not
transgressing the mucogingival junction.
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such cases sometimes the free gingiva is not pigmented
(Figure 5) [3,7,48]. Occasionally, the alveolar mucosa is
affected, and again the mucogingival junction is not trans-
gressed (Figure 6). Oral pigmentation gradually appears
during the first two decades of life [48] but affected sub-
jects may be unaware of it [48,50].
The extent and intensity of physiological oral pig-
mentation increases with age [52,53], concurrently with
an increase in the number of oral melanocytes [15], per-
haps because of the effects of potentially melanogenic
stimuli such as recurrent minor functional injury, in-
flammatory conditions, medication, or tobacco smoke
are cumulative [3].
The global frequency of physiological oral pigmenta-
tion in different racial/ethnic groups is unknown; but it
has been reported that about 95% of healthy black per-
sons in the United States are affected; that pigmentation
is more extensive in the anterior than in the posterior
portion of the mouth; and that when the gingiva is
affected the buccal/labial surfaces are more intensely
pigmented than the lingual/palatal surfaces [7]. It has
been reported in one study from South Africa that oral
pigmentation occurs in 98% of black persons [54].
Eighty to a hundred percent of Australian Aborigines
have physiological oral pigmentation with equal gender
distribution [52]. By contrast Fry and Almeyda [55] have
reported that only about 5% of white people in England
have physiological buccal mucosal pigmentation. In
general, it appears that persons with more darkly pig-
mented skin are more likely to have physiological oral
pigmentation [7].Summary
Melanocytes can adjust and respond to biological, physical
and chemical stimuli in their microenvironment, and can
in turn generate physical and biochemical signals which
may affect that microenvironment. Melanocytes have the
capacity to mediate antimicrobial and immune responses
and to act as neuroendocrine cells, and they produce
melanin that provides protection from environmental
stressors such as UV radiation, reactive oxygen species
and free radicals. Why certain persons are more affected
by physiological oral pigmentation is unknown, but cer-
tainly it occurs predominantly in darker skinned persons.Consent
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